Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Trapman

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Medical and Veterinary Entomology|January 12, 2005
The role of volatile semiochemicals in mediating host location and selection by nuisance and disease-transmitting cattle fliesM A Birkett, N Agelopoulos, K-M V Jensen, et al.
The Journal of Urology|June 17, 1998
Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancerA Gotoh, S C Ko, T Shirakawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivityC Ris-Stalpers, G G Kuiper, P W Faber, et al.
Genes, Chromosomes & Cancer|June 13, 1998
Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancerJ Adélaïde, M Chaffanet, A Imbert, et al.
Biochemical and Biophysical Research Communications|May 31, 1988
Cloning, structure and expression of a cDNA encoding the human androgen receptorJ Trapman, P Klaassen, G G Kuiper, et al.
The American Journal of Pathology|April 1, 1994
Androgen receptor status in localized and locally progressive hormone refractory human prostate cancerJ A Ruizeveld de Winter, P J Janssen, H M Sleddens, et al.
The Journal of Pathology|January 13, 2006
The PTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletionP C M S Verhagen, P W van Duijn, K G L Hermans, et al.
Genes, Chromosomes & Cancer|January 14, 1999
Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograftD C Van Alewijk, M M Van der Weiden, B J Eussen, et al.
Molecular and Cellular Endocrinology|November 1, 1989
Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptorJ H van Laar, M M Voorhorst-Ogink, N D Zegers, et al.
Oncogene|February 4, 2014
Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancerI Teles Alves, T Hartjes, E McClellan, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Medical and Veterinary Entomology|January 12, 2005
The role of volatile semiochemicals in mediating host location and selection by nuisance and disease-transmitting cattle fliesM A Birkett, N Agelopoulos, K-M V Jensen, et al.
The Journal of Urology|June 17, 1998
Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancerA Gotoh, S C Ko, T Shirakawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivityC Ris-Stalpers, G G Kuiper, P W Faber, et al.
Genes, Chromosomes & Cancer|June 13, 1998
Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancerJ Adélaïde, M Chaffanet, A Imbert, et al.
Biochemical and Biophysical Research Communications|May 31, 1988
Cloning, structure and expression of a cDNA encoding the human androgen receptorJ Trapman, P Klaassen, G G Kuiper, et al.
The American Journal of Pathology|April 1, 1994
Androgen receptor status in localized and locally progressive hormone refractory human prostate cancerJ A Ruizeveld de Winter, P J Janssen, H M Sleddens, et al.
The Journal of Pathology|January 13, 2006
The PTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletionP C M S Verhagen, P W van Duijn, K G L Hermans, et al.
Genes, Chromosomes & Cancer|January 14, 1999
Identification of a homozygous deletion at 8p12-21 in a human prostate cancer xenograftD C Van Alewijk, M M Van der Weiden, B J Eussen, et al.
Molecular and Cellular Endocrinology|November 1, 1989
Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptorJ H van Laar, M M Voorhorst-Ogink, N D Zegers, et al.
Oncogene|February 4, 2014
Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancerI Teles Alves, T Hartjes, E McClellan, et al.
Pageof 14